 | • レポートコード：QFJ1-5770 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、心不全治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断、予後、治療オプション＆治療アルゴリズム）、用途別市場規模（病院、診療所、医学研究機関）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・心不全治療薬の市場動向 ・企業の競争状況、市場シェア ・心不全治療薬の種類別市場規模と予測2016-2027（診断、予後、治療オプション＆治療アルゴリズム） ・心不全治療薬の用途別市場規模と予測2016-2027（病院、診療所、医学研究機関） ・心不全治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・心不全治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・心不全治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・心不全治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・心不全治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer、Cynokinetics、Les Laboratoires Servier、Merck & Co.、Novartis、Procoralan、Bristol-Myers Squibb Company、Cardiorentis AG、CVie Therapeutics Limited、Orion Corporation、PhaseBio Pharmaceuticals、Market Segment by Product Type、B-Blockers、Calcium Channel Blockers、Cardiac Glycosides、Diuretics、Morphine、Vasodilators/Nitrates） ・結論 |
Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body’s needs. Signs and symptoms commonly include shortness of breath, excessive tiredness, and leg swelling.The shortness of breath is usually worse with exercise, while lying down, and may wake the person at night.A limited ability to exercise is also a common feature. Chest pain, including angina, does not typically occur due to heart failure.
Market Analysis and Insights: Global Heart Failure Therapeutics Market
The global Heart Failure Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Heart Failure Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Heart Failure Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Heart Failure Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Heart Failure Therapeutics market.
Global Heart Failure Therapeutics Scope and Market Size
Heart Failure Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Heart Failure Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Diagnosis
Prognosis
Treatment Options and Treatment Algorithm
Segment by Application
Hospital
Clinic
Medical Research Organization
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bayer
Cynokinetics
Les Laboratoires Servier
Merck & Co.
Novartis
Procoralan
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Orion Corporation
PhaseBio Pharmaceuticals
Market Segment by Product Type
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Heart Failure Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnosis
1.2.3 Prognosis
1.2.4 Treatment Options and Treatment Algorithm
1.3 Market by Application
1.3.1 Global Heart Failure Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Research Organization
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Heart Failure Therapeutics Market Perspective (2016-2027)
2.2 Heart Failure Therapeutics Growth Trends by Regions
2.2.1 Heart Failure Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Heart Failure Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Heart Failure Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Heart Failure Therapeutics Industry Dynamic
2.3.1 Heart Failure Therapeutics Market Trends
2.3.2 Heart Failure Therapeutics Market Drivers
2.3.3 Heart Failure Therapeutics Market Challenges
2.3.4 Heart Failure Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Heart Failure Therapeutics Players by Revenue
3.1.1 Global Top Heart Failure Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Heart Failure Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Heart Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Heart Failure Therapeutics Revenue
3.4 Global Heart Failure Therapeutics Market Concentration Ratio
3.4.1 Global Heart Failure Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Heart Failure Therapeutics Revenue in 2020
3.5 Heart Failure Therapeutics Key Players Head office and Area Served
3.6 Key Players Heart Failure Therapeutics Product Solution and Service
3.7 Date of Enter into Heart Failure Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Heart Failure Therapeutics Breakdown Data by Type
4.1 Global Heart Failure Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Heart Failure Therapeutics Forecasted Market Size by Type (2022-2027)
5 Heart Failure Therapeutics Breakdown Data by Application
5.1 Global Heart Failure Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Heart Failure Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Heart Failure Therapeutics Market Size (2016-2027)
6.2 North America Heart Failure Therapeutics Market Size by Type
6.2.1 North America Heart Failure Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Heart Failure Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Heart Failure Therapeutics Market Size by Type (2016-2027)
6.3 North America Heart Failure Therapeutics Market Size by Application
6.3.1 North America Heart Failure Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Heart Failure Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Heart Failure Therapeutics Market Size by Application (2016-2027)
6.4 North America Heart Failure Therapeutics Market Size by Country
6.4.1 North America Heart Failure Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Heart Failure Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Heart Failure Therapeutics Market Size (2016-2027)
7.2 Europe Heart Failure Therapeutics Market Size by Type
7.2.1 Europe Heart Failure Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Heart Failure Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Heart Failure Therapeutics Market Size by Type (2016-2027)
7.3 Europe Heart Failure Therapeutics Market Size by Application
7.3.1 Europe Heart Failure Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Heart Failure Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Heart Failure Therapeutics Market Size by Application (2016-2027)
7.4 Europe Heart Failure Therapeutics Market Size by Country
7.4.1 Europe Heart Failure Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Heart Failure Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Heart Failure Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Heart Failure Therapeutics Market Size by Type
8.2.1 Asia-Pacific Heart Failure Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Heart Failure Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Heart Failure Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Heart Failure Therapeutics Market Size by Application
8.3.1 Asia-Pacific Heart Failure Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Heart Failure Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Heart Failure Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Heart Failure Therapeutics Market Size by Region
8.4.1 Asia-Pacific Heart Failure Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Heart Failure Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Heart Failure Therapeutics Market Size (2016-2027)
9.2 Latin America Heart Failure Therapeutics Market Size by Type
9.2.1 Latin America Heart Failure Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Heart Failure Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Heart Failure Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Heart Failure Therapeutics Market Size by Application
9.3.1 Latin America Heart Failure Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Heart Failure Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Heart Failure Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Heart Failure Therapeutics Market Size by Country
9.4.1 Latin America Heart Failure Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Heart Failure Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Heart Failure Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Heart Failure Therapeutics Market Size by Type
10.2.1 Middle East & Africa Heart Failure Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Heart Failure Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Heart Failure Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Heart Failure Therapeutics Market Size by Application
10.3.1 Middle East & Africa Heart Failure Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Heart Failure Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Heart Failure Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Heart Failure Therapeutics Market Size by Country
10.4.1 Middle East & Africa Heart Failure Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Heart Failure Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Heart Failure Therapeutics Introduction
11.1.4 Bayer Revenue in Heart Failure Therapeutics Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Cynokinetics
11.2.1 Cynokinetics Company Details
11.2.2 Cynokinetics Business Overview
11.2.3 Cynokinetics Heart Failure Therapeutics Introduction
11.2.4 Cynokinetics Revenue in Heart Failure Therapeutics Business (2016-2021)
11.2.5 Cynokinetics Recent Development
11.3 Les Laboratoires Servier
11.3.1 Les Laboratoires Servier Company Details
11.3.2 Les Laboratoires Servier Business Overview
11.3.3 Les Laboratoires Servier Heart Failure Therapeutics Introduction
11.3.4 Les Laboratoires Servier Revenue in Heart Failure Therapeutics Business (2016-2021)
11.3.5 Les Laboratoires Servier Recent Development
11.4 Merck & Co.
11.4.1 Merck & Co. Company Details
11.4.2 Merck & Co. Business Overview
11.4.3 Merck & Co. Heart Failure Therapeutics Introduction
11.4.4 Merck & Co. Revenue in Heart Failure Therapeutics Business (2016-2021)
11.4.5 Merck & Co. Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Heart Failure Therapeutics Introduction
11.5.4 Novartis Revenue in Heart Failure Therapeutics Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Procoralan
11.6.1 Procoralan Company Details
11.6.2 Procoralan Business Overview
11.6.3 Procoralan Heart Failure Therapeutics Introduction
11.6.4 Procoralan Revenue in Heart Failure Therapeutics Business (2016-2021)
11.6.5 Procoralan Recent Development
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Details
11.7.2 Bristol-Myers Squibb Company Business Overview
11.7.3 Bristol-Myers Squibb Company Heart Failure Therapeutics Introduction
11.7.4 Bristol-Myers Squibb Company Revenue in Heart Failure Therapeutics Business (2016-2021)
11.7.5 Bristol-Myers Squibb Company Recent Development
11.8 Cardiorentis AG
11.8.1 Cardiorentis AG Company Details
11.8.2 Cardiorentis AG Business Overview
11.8.3 Cardiorentis AG Heart Failure Therapeutics Introduction
11.8.4 Cardiorentis AG Revenue in Heart Failure Therapeutics Business (2016-2021)
11.8.5 Cardiorentis AG Recent Development
11.9 CVie Therapeutics Limited
11.9.1 CVie Therapeutics Limited Company Details
11.9.2 CVie Therapeutics Limited Business Overview
11.9.3 CVie Therapeutics Limited Heart Failure Therapeutics Introduction
11.9.4 CVie Therapeutics Limited Revenue in Heart Failure Therapeutics Business (2016-2021)
11.9.5 CVie Therapeutics Limited Recent Development
11.10 Orion Corporation
11.10.1 Orion Corporation Company Details
11.10.2 Orion Corporation Business Overview
11.10.3 Orion Corporation Heart Failure Therapeutics Introduction
11.10.4 Orion Corporation Revenue in Heart Failure Therapeutics Business (2016-2021)
11.10.5 Orion Corporation Recent Development
11.11 PhaseBio Pharmaceuticals
11.11.1 PhaseBio Pharmaceuticals Company Details
11.11.2 PhaseBio Pharmaceuticals Business Overview
11.11.3 PhaseBio Pharmaceuticals Heart Failure Therapeutics Introduction
11.11.4 PhaseBio Pharmaceuticals Revenue in Heart Failure Therapeutics Business (2016-2021)
11.11.5 PhaseBio Pharmaceuticals Recent Development
11.12 Market Segment by Product Type
11.12.1 Market Segment by Product Type Company Details
11.12.2 Market Segment by Product Type Business Overview
11.12.3 Market Segment by Product Type Heart Failure Therapeutics Introduction
11.12.4 Market Segment by Product Type Revenue in Heart Failure Therapeutics Business (2016-2021)
11.12.5 Market Segment by Product Type Recent Development
11.13 B-Blockers
11.13.1 B-Blockers Company Details
11.13.2 B-Blockers Business Overview
11.13.3 B-Blockers Heart Failure Therapeutics Introduction
11.13.4 B-Blockers Revenue in Heart Failure Therapeutics Business (2016-2021)
11.13.5 B-Blockers Recent Development
11.14 Calcium Channel Blockers
11.14.1 Calcium Channel Blockers Company Details
11.14.2 Calcium Channel Blockers Business Overview
11.14.3 Calcium Channel Blockers Heart Failure Therapeutics Introduction
11.14.4 Calcium Channel Blockers Revenue in Heart Failure Therapeutics Business (2016-2021)
11.14.5 Calcium Channel Blockers Recent Development
11.15 Cardiac Glycosides
11.15.1 Cardiac Glycosides Company Details
11.15.2 Cardiac Glycosides Business Overview
11.15.3 Cardiac Glycosides Heart Failure Therapeutics Introduction
11.15.4 Cardiac Glycosides Revenue in Heart Failure Therapeutics Business (2016-2021)
11.15.5 Cardiac Glycosides Recent Development
11.16 Diuretics
11.16.1 Diuretics Company Details
11.16.2 Diuretics Business Overview
11.16.3 Diuretics Heart Failure Therapeutics Introduction
11.16.4 Diuretics Revenue in Heart Failure Therapeutics Business (2016-2021)
11.16.5 Diuretics Recent Development
11.17 Morphine
11.17.1 Morphine Company Details
11.17.2 Morphine Business Overview
11.17.3 Morphine Heart Failure Therapeutics Introduction
11.17.4 Morphine Revenue in Heart Failure Therapeutics Business (2016-2021)
11.17.5 Morphine Recent Development
11.18 Vasodilators/Nitrates
11.18.1 Vasodilators/Nitrates Company Details
11.18.2 Vasodilators/Nitrates Business Overview
11.18.3 Vasodilators/Nitrates Heart Failure Therapeutics Introduction
11.18.4 Vasodilators/Nitrates Revenue in Heart Failure Therapeutics Business (2016-2021)
11.18.5 Vasodilators/Nitrates Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Heart Failure Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnosis
Table 3. Key Players of Prognosis
Table 4. Key Players of Treatment Options and Treatment Algorithm
Table 5. Global Heart Failure Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Heart Failure Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Heart Failure Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Heart Failure Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Heart Failure Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Heart Failure Therapeutics Market Share by Regions (2022-2027)
Table 11. Heart Failure Therapeutics Market Trends
Table 12. Heart Failure Therapeutics Market Drivers
Table 13. Heart Failure Therapeutics Market Challenges
Table 14. Heart Failure Therapeutics Market Restraints
Table 15. Global Heart Failure Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Heart Failure Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Heart Failure Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heart Failure Therapeutics as of 2020)
Table 18. Ranking of Global Top Heart Failure Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Heart Failure Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Heart Failure Therapeutics Product Solution and Service
Table 22. Date of Enter into Heart Failure Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Heart Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Heart Failure Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Heart Failure Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Heart Failure Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Heart Failure Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Heart Failure Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Heart Failure Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Heart Failure Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Heart Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Heart Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Heart Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Heart Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Heart Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Heart Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Heart Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Heart Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Heart Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Heart Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Heart Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Heart Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Heart Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Heart Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Heart Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Heart Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Heart Failure Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Heart Failure Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Heart Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Heart Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Heart Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Heart Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Heart Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Heart Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Heart Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Heart Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Heart Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Heart Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Heart Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Heart Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bayer Company Details
Table 63. Bayer Business Overview
Table 64. Bayer Heart Failure Therapeutics Product
Table 65. Bayer Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Bayer Recent Development
Table 67. Cynokinetics Company Details
Table 68. Cynokinetics Business Overview
Table 69. Cynokinetics Heart Failure Therapeutics Product
Table 70. Cynokinetics Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Cynokinetics Recent Development
Table 72. Les Laboratoires Servier Company Details
Table 73. Les Laboratoires Servier Business Overview
Table 74. Les Laboratoires Servier Heart Failure Therapeutics Product
Table 75. Les Laboratoires Servier Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Les Laboratoires Servier Recent Development
Table 77. Merck & Co. Company Details
Table 78. Merck & Co. Business Overview
Table 79. Merck & Co. Heart Failure Therapeutics Product
Table 80. Merck & Co. Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Merck & Co. Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Heart Failure Therapeutics Product
Table 85. Novartis Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Procoralan Company Details
Table 88. Procoralan Business Overview
Table 89. Procoralan Heart Failure Therapeutics Product
Table 90. Procoralan Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Procoralan Recent Development
Table 92. Bristol-Myers Squibb Company Company Details
Table 93. Bristol-Myers Squibb Company Business Overview
Table 94. Bristol-Myers Squibb Company Heart Failure Therapeutics Product
Table 95. Bristol-Myers Squibb Company Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Bristol-Myers Squibb Company Recent Development
Table 97. Cardiorentis AG Company Details
Table 98. Cardiorentis AG Business Overview
Table 99. Cardiorentis AG Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Cardiorentis AG Recent Development
Table 101. CVie Therapeutics Limited Company Details
Table 102. CVie Therapeutics Limited Business Overview
Table 103. CVie Therapeutics Limited Heart Failure Therapeutics Product
Table 104. CVie Therapeutics Limited Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 105. CVie Therapeutics Limited Recent Development
Table 106. Orion Corporation Company Details
Table 107. Orion Corporation Business Overview
Table 108. Orion Corporation Heart Failure Therapeutics Product
Table 109. Orion Corporation Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Orion Corporation Recent Development
Table 111. PhaseBio Pharmaceuticals Company Details
Table 112. PhaseBio Pharmaceuticals Business Overview
Table 113. PhaseBio Pharmaceuticals Heart Failure Therapeutics Product
Table 114. PhaseBio Pharmaceuticals Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 115. PhaseBio Pharmaceuticals Recent Development
Table 116. Market Segment by Product Type Company Details
Table 117. Market Segment by Product Type Business Overview
Table 118. Market Segment by Product Type Heart Failure Therapeutics Product
Table 119. Market Segment by Product Type Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 120. Market Segment by Product Type Recent Development
Table 121. B-Blockers Company Details
Table 122. B-Blockers Business Overview
Table 123. B-Blockers Heart Failure Therapeutics Product
Table 124. B-Blockers Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 125. B-Blockers Recent Development
Table 126. Calcium Channel Blockers Company Details
Table 127. Calcium Channel Blockers Business Overview
Table 128. Calcium Channel Blockers Heart Failure Therapeutics Product
Table 129. Calcium Channel Blockers Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 130. Calcium Channel Blockers Recent Development
Table 131. Cardiac Glycosides Company Details
Table 132. Cardiac Glycosides Business Overview
Table 133. Cardiac Glycosides Heart Failure Therapeutics Product
Table 134. Cardiac Glycosides Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 135. Cardiac Glycosides Recent Development
Table 136. Diuretics Company Details
Table 137. Diuretics Business Overview
Table 138. Diuretics Heart Failure Therapeutics Product
Table 139. Diuretics Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 140. Diuretics Recent Development
Table 141. Morphine Company Details
Table 142. Morphine Business Overview
Table 143. Morphine Heart Failure Therapeutics Product
Table 144. Morphine Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 145. Morphine Recent Development
Table 146. Vasodilators/Nitrates Company Details
Table 147. Vasodilators/Nitrates Business Overview
Table 148. Vasodilators/Nitrates Heart Failure Therapeutics Product
Table 149. Vasodilators/Nitrates Revenue in Heart Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 150. Vasodilators/Nitrates Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Heart Failure Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Diagnosis Features
Figure 3. Prognosis Features
Figure 4. Treatment Options and Treatment Algorithm Features
Figure 5. Global Heart Failure Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Medical Research Organization Case Studies
Figure 9. Heart Failure Therapeutics Report Years Considered
Figure 10. Global Heart Failure Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Heart Failure Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Heart Failure Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Heart Failure Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Heart Failure Therapeutics Market Share by Players in 2020
Figure 15. Global Top Heart Failure Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heart Failure Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Heart Failure Therapeutics Revenue in 2020
Figure 17. Global Heart Failure Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Heart Failure Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Heart Failure Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Heart Failure Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Heart Failure Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Heart Failure Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Heart Failure Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Heart Failure Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Heart Failure Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Heart Failure Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Heart Failure Therapeutics Market Share by Region (2016-2027)
Figure 39. China Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Heart Failure Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Heart Failure Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Heart Failure Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Heart Failure Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Heart Failure Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Heart Failure Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Heart Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bayer Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 59. Cynokinetics Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 60. Les Laboratoires Servier Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 61. Merck & Co. Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 63. Procoralan Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 64. Bristol-Myers Squibb Company Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 65. Cardiorentis AG Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 66. CVie Therapeutics Limited Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 67. Orion Corporation Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 68. PhaseBio Pharmaceuticals Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 69. Market Segment by Product Type Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 70. B-Blockers Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 71. Calcium Channel Blockers Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 72. Cardiac Glycosides Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 73. Diuretics Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 74. Morphine Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 75. Vasodilators/Nitrates Revenue Growth Rate in Heart Failure Therapeutics Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界の心不全治療市場規模・現状・予測（2021年-2027年） The main treatment for heart failure is etiological treatment.Because heart failure is the ultimate state of the heart, the causes of heart failure are different.Some people may have hyperthyroidism induced heart failure, and the treatment plan is to actively correct hyperthyroidism.Some people beca…- 世界の心不全検査市場規模・現状・予測（2021年-2027年） Heart failure is due to the contraction of the heart function and (or) diastolic function obstacle, blood vein change can not be fully out of the heart, lead to venous blood pooling system, arterial blood perfusion system is insufficient, causing cardiovascular disorders, the disorder syndrome focus…
- 世界の高血圧＆心不全治療薬市場規模・現状・予測（2021年-2027年） Hypertension and Heart Failure Drugs such as β-blockers, angiotensin-converting enzyme inhibitiors, angiotensin receptor blockers, aldosterone receptor blockers, hydralazine and nitrates, which have shown mortality benefit in CHF and exert antihypertensive effects, are used as first-line agents to c…
- 急性心不全(AHF)治療薬のグローバル市場調査 2019年 The global Acute Heart Failure (AHF) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Acute Heart Failure (AHF) Therapeutics volume and value at global level, regional level and company …
- 世界の弁膜性心疾患治療市場規模・現状・予測（2021年-2027年） Valvular heart disease is characterized by damage to or a defect in one of the four heart valves namely the mitral valve, aortic valve, tricuspid valve, and pulmonary valve. Market Analysis and Insights: Global Valvular Heart Disease Treatment Market The global Valvular Heart Disease Treatment marke…